You have 9 free searches left this month | for more free features.

NaI-IRI

Showing 1 - 25 of 88

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Triple Negative Breast Cancer, Brain Metastases Trial in Saint Louis (Pembrolizumab, Liposomal Irinotecan)

Recruiting
  • Triple Negative Breast Cancer
  • Brain Metastases
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 1, 2022

Adenocarcinoma Metastatic, Biliary Tract Cancer, Adenocarcinoma of the Biliary Tract Trial in Ulm (Arm NaI-IRI + 5-FU +

Active, not recruiting
  • Adenocarcinoma Metastatic
  • +6 more
  • Arm NaI-IRI + 5-FU + Leucovorin (Arm A)
  • Arm Cisplatin + Gemcitabine (Arm B)
  • Ulm, Germany
    Universitätsklinikum Ulm
Apr 28, 2021

Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,

Not yet recruiting
  • Metastatic Gastric Adenocarcinoma
  • +2 more
  • nal-IRI /Experimental
  • +2 more
  • (no location specified)
Jun 25, 2023

Oncology, Neuroendocrine Carcinoma Trial in United Kingdom (Liposomal Irinotecan, Fluorouracil, Folinic Acid)

Active, not recruiting
  • Oncology
  • Neuroendocrine Carcinoma
  • Liposomal Irinotecan
  • +3 more
  • Glasgow, United Kingdom
  • +3 more
Dec 2, 2022

GEP-NET Trial in Taiwan (nanoliposomal irinotecan plus carboplatin)

Not yet recruiting
  • GEP-NET
  • nanoliposomal irinotecan plus carboplatin
  • Kaohsiung, Taiwan
  • +5 more
May 17, 2022

Metastatic Pancreatic Cancer Trial in Amsterdam (S1 + Nal-IRI, Nal-IRI+Leucovorin+5-FU)

Recruiting
  • Metastatic Pancreatic Cancer
  • Amsterdam, Netherlands
    Academic Medical Center, Medical Oncology
Jan 14, 2021

Ischemia Reperfusion Injury Trial in Philadelphia (Conjugated Estrogen, Normal saline)

Recruiting
  • Ischemia Reperfusion Injury
  • Conjugated Estrogen
  • Normal saline
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Sep 22, 2022

Peritoneal Carcinomatosis, Peritoneal Metastases, Colorectal Cancer Trial in Ghent (PIPAC with Nal-IRI)

Recruiting
  • Peritoneal Carcinomatosis
  • +7 more
  • PIPAC with Nal-IRI
  • Ghent, East-Flanders, Belgium
    UZ Ghent
Dec 28, 2022

RWE on mPDAC Long-term Survival After Treatment With Liposomal

Recruiting
  • Pancreatic Cancer Metastatic
    • Munich, Germany
      Klinikum der Universität München, - Anstalt des öffentlichen Rec
    Nov 24, 2023

    Landscape and Survival in Metastatic Pancreatic Cancer After

    Recruiting
    • Pancreatic Neoplasms
      • Seoul, Korea, Republic of
        Yonsei University Health System, Severance Hospital
      Oct 19, 2022

      Solid Tumor, Non Small Cell Lung Cancer, Pancreatic Cancer Trial in Israel, United States (CM-24 and Nivolumab - Dose

      Recruiting
      • Solid Tumor
      • +6 more
      • CM-24 and Nivolumab - Dose Escalation
      • +4 more
      • Scottsdale, Arizona
      • +10 more
      Jan 17, 2023

      Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Phoenix, Arizona
      • +5 more
      Dec 15, 2022

      Metastatic Pancreatic Cancer Trial in France, Martinique (Irinotecan Liposomal Injection, 5-FU/LV, Nab-Paclitaxel)

      Recruiting
      • Metastatic Pancreatic Cancer
      • Irinotecan Liposomal Injection
      • +3 more
      • Amiens, France
      • +35 more
      Mar 23, 2022

      Liver Diseases Trial (pneumatic tourniquet, No inflation)

      Completed
      • Liver Diseases
      • pneumatic tourniquet
      • No inflation
      • Lille, France
        Hop Claude Huriez Chu Lille
      Oct 14, 2022

      Myocardial Reperfusion Injury, Hypoxia, Hyperoxia Trial (Hypoxic-hyperoxic preconditioning, Placebo)

      Completed
      • Myocardial Reperfusion Injury
      • +3 more
      • Hypoxic-hyperoxic preconditioning
      • Placebo
      • (no location specified)
      May 6, 2022

      Breast Cancer Metastatic Trial in Spain (Irinotecan Hydrochloride)

      Recruiting
      • Breast Cancer Metastatic
      • Irinotecan Hydrochloride
      • Badalona, Spain
      • +19 more
      Jan 18, 2023

      Diagnosis of Ischemic Heart Disease Determined by Fraction Flow

      Recruiting
      • Coronary Artery Disease
        • Beijing, Beijing, China
          Fuwai Hospital
        Sep 7, 2023

        Pancreas Cancer Trial in Seoul (Vactosertib)

        Recruiting
        • Pancreas Cancer
        • Seoul, Korea, Republic of
          Samsung Medical Center
        Jun 13, 2022

        EPIPAGE 2 - 10-year Follow-up (RECONAI PROJECT)

        Not yet recruiting
        • Pre-Term
        • Development, Child
          • (no location specified)
          Feb 16, 2022

          Liver Transplantation Trial in France (temporary porto-caval shunt)

          Recruiting
          • Liver Transplantation
          • temporary porto-caval shunt
          • Bordeaux, France
          • +4 more
          Apr 29, 2022

          Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal

          Recruiting
          • Colorectal Adenocarcinoma
          • +13 more
          • Nanoliposomal Irinotecan
          • Trifluridine and Tipiracil Hydrochloride
          • Atlanta, Georgia
          • +2 more
          Jan 6, 2023

          Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Anyang, Seoul (NASOX)

          Recruiting
          • Pancreatic Cancer
          • Pancreatic Ductal Adenocarcinoma
          • Anyang, Gyeonggi, Korea, Republic of
          • +1 more
          Jul 16, 2021

          Metastatic Pancreatic Cancer Trial in Singapore (Low Dose OXIRI (LD-OXIRI))

          Not yet recruiting
          • Metastatic Pancreatic Cancer
          • Low Dose OXIRI (LD-OXIRI)
          • Singapore, Singapore
            National Cancer Centre, Singapore
          Jun 29, 2023

          Colon Cancer, Rectal Cancer Trial in United States (TAS-102, oxaliplatin, irinotecan with bevacizumab)

          Not yet recruiting
          • Colon Cancer
          • Rectal Cancer
          • TAS-102, oxaliplatin, irinotecan with bevacizumab
          • Elizabeth, New Jersey
          • +6 more
          Apr 7, 2023